Abiopharma

News list

(99% Neutral) Disc Medicine, Inc. (GMTX) Announces Clinical Development Update

Full text

News bot Oct. 22, 2025, 1:14 p.m.
📋 Disc Medicine, Inc. (GMTX) - Clinical Trial Update

Filing Date: 2025-10-22

Accepted: 2025-10-22 09:11:57

Event Type: Clinical Trial Update
Event Details:
Gemini Therapeutics Inc. (the company became a subdivision of the company Disc Medicine (NASDAQ : IRON)) (GMTX) Announces Clinical Trial Update Gemini Therapeutics Inc. (the company became a subdivision of the company Disc Medicine (NASDAQ : IRON)) (GMTX) provided an update on its clinical development programs. Clinical Development Highlights:
Collaboration: XLP
Updated Timeline: October 20, 2025
targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. Cautionary Statement Regarding Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995
💼 Business Developments:

No business developments data available.
Structured Data:
- Company Name: Gemini Therapeutics Inc. (the company became a subdivision of the company Disc Medicine (NASDAQ : IRON))
- CIK: 0001816736
- Ticker Symbol: GMTX
- Period End Date: 2025-10-20
- Document Type: 8-K